Clinical Trial: Pilot Study of Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer

U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07675876) titled 'Pilot Study of Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer' on June 16.

Brief Summary: Brief Summary

This prospective, open-label pilot study is designed to evaluate the safety, tolerability, feasibility, and preliminary clinical activity of inhaled cromolyn sodium administered by dry powder inhalation in participants with locally advanced lung cancer.

Cromolyn sodium is an FDA-approved mast cell stabilizer with an established safety profile in respiratory disease. Increasing evidence suggests that inflammatory signaling, mast cell activation, and stromal remodeling contribute to tumor progression, immune ...